Ms Gabriela Salerno

Gabriela Salerno


Intellectual Property

Do ANVISA's new guidelines jeopardise the patentability of patent applications?
Brazil | 08 March 2021

The National Health Surveillance Agency recently published four guidelines on its prior consent procedure, which all pharmaceutical patent applications in Brazil must undergo before the Brazilian Patent and Trademark Office (BRPTO) conducts the technical examination. However, applicants should remember that the final decision on the patentability of pharmaceutical patent applications is made exclusively by the BRPTO.